Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia

American Journal of Public Health

Volumn 98, Issue 3, 2008, Pages 515-519

  Wood, Evan ^a,b   Montaner, Julio S G ^a,b   Li, Kathy ^a   Zhang, Ruth ^a   Barney, Lucy ^c   Strathdee, Steffanie A ^a,d   Tyndall, Mark W ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG ABUSE; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADOLESCENT; ADULT; BRITISH COLUMBIA; CANADA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; POPULATION GROUPS; PREVALENCE; PROSPECTIVE STUDIES; RISK-TAKING; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 40449103296     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.114595     Document Type: Article

References (30)

1. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001;91:1060-1068.
2. Joint United Nations Programme on HIV/AIDS. 2006 report on the global AIDS epidemic. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport/ default.asp. Accessed September 15, 2006.
3. Horton R. Indigenous peoples: time to act now for equity and health. Lancet. 2006;367:1705-1707.
4. Stephens C, Porter J, Nettleton C, Willis R. Disappearing, displaced, and undervalued: a call to action for Indigenous health worldwide. Lancet. 2006;367:2019-2028.
5. Stephens C, Nettleton C, Porter J, Willis R, Clark S. Indigenous peoples' health - why are they behind everyone, everywhere? Lancet. 2005;366:10-13.
6. Anderson I, Crengle S, Kamaka ML, Chen TH, Palafox N, Jackson-Pulver L. Indigenous health in Australia, New Zealand, and the Pacific. Lancet. 2006;367:1775-1785.
7. Perkins JJ, Sanson-Fisher RW, Blunden S, Lunnay D, Redman S, Hensley MJ. The prevalence of drug use in urban aboriginal communities. Addiction. 1994;89:1319-1331.
8. Breen C, Roxburgh A, Degenhardt L. Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003. Drug Alcohol Rev. 2005;24:353-358.
9. Craib KJ, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003;168:19-24.
10. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59-F65.
11. Wood E, Kerr T, Lloyd-Smith E, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J. 2004;1, 9.
12. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366:316-318.
13. Wood E, Tyndall MW, Zhang R, et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354:2512-2514.
14. Wood E, Kerr T, Palepu A, et al. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect. 2006;52:233-236.
15. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002;30:335-341.
16. Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887-893.
17. deBeck K, Wood E, Montaner J, Kerr T. Canada's 2003 renewed drug strategy - an evidence-based review. HIV AIDS Policy Law Rev. 2006;11:1, 5-12.
18. Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: HIV risk behaviours among injection drug users. Int J Drug Policy. 1999;10:25-38.
19. Wood E, Tyndall MW, Spittal PM, et al. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ. 2003;168:165-169.
20. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999;114:14-29.
21. PrisonJustice.CA. Facts and statistics. Available at: http://www.prisonjustice.ca/politics/facts_stats.html. Accessed January 16, 2007.
22. Canadian Foundation for Drug Policy. Drugs and drug policy in Canada. Available at: http://www.cfdp.ca/sen8ex1.htm. Accessed January 16, 2007.
23. Wood E, Spittal P, Small W, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ. 2004;170:1551-1556.
24. Small D. The war on drugs is a war on racial justice. Soc Res. 2001;68:896-903.
25. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226-1231.
26. Des Jarlais DC. Harm reduction - a framework for incorporating science into drug policy. Am J Public Health. 1995;85:10-12.
27. Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175:1399-1404.
28. Benoit C, Carroll D, Chaudhry M. In search of a healing place: Aboriginal women in Vancouver's Downtown Eastside. Soc Sci Med. 2003;56:821-833.
29. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657-1661.
30. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253-263.